AI Gone Wild

Dear Reader,

Have you ever been driving — perhaps into the office on your daily commute — and heard a commercial come on the radio?

Not just any commercial, though… an ad for a company you’ve never heard of, and the radio broadcaster describes it using such pretentious jargon that you feel dumber afterward for not understanding a single word?

Well, this used to happen to me all the time when I was listening to NPR, a station that, sadly, has become so politicized that much of the news content is hard to listen to. (I still listen from time to time, though.)

But one of those commercials went something like this: "C3.ai is a leading enterprise AI software provider that builds enterprise-scale AI applications and accelerates digital transformation."

Oh, how I wish they would just say what the company does!

I’m picking on C3.ai because there are so many companies out there competing for attention in the artificial intelligence (AI) space.

After chatbot ChatGPT hit the scene, the market saw AI companies explode in value for seemingly little reason.

So I thought it’d be a good idea to break down some prominent AI companies trading in the market right now and see if we can figure out what they actually do. And maybe it’ll give us some insight into which companies are going to come out on top of this dot-com-style run-up.

First let’s start with the aforementioned “enterprise” AI company…

C3.ai (NYSE: AI)

You’ve probably heard a lot about C3.ai in the market news for its ludicrous run-up this year.

Year to date, it’s up over 250%…

Now, the term enterprise simply refers to the fact that the company works with organizations rather than individuals.

So we already know that it’s a large company with a diverse customer base.

But what does it do?

Well, C3.ai creates AI software and applications for various industries, including energy, manufacturing, health care, and financial services. It offers four products, but its most notable is the C3 AI Suite, which combines big data, AI, and cloud computing to help organizations analyze and derive insights from large volumes of data. Think oil and gas pipelines, complex financial accounts, healthcare charts, and government contracts.

By partnering with C3.ai, companies can easily collect, store, process, and analyze data, and then leverage machine learning algorithms and predictive analytics to generate actionable insights, including predictive maintenance, inventory optimization, fraud detection, energy management, and customer engagement. These applications help businesses make data-driven decisions, optimize operations, improve efficiency, and enhance customer experiences.

This company touches nearly every industry, and what I like is that it helps organizations harness the power of AI and big data to solve complex business challenges. It has a rich customer base, including Shell, the U.S. Air Force, and Raytheon.

A company that sells a product or service to other large companies is going to be a winner for years to come.

Let’s move on to the healthcare space, as AI is touted as a miracle worker for its ability to bring new drugs online cheaper and faster.

Recursion Pharmaceuticals (NASDAQ: RXRX)

You’ve probably never heard of Recursion Pharmaceuticals, but it landed on my radar last week after it was announced that chipmaker Nvidia invested $50 million in the company with the goal of furthering AI in drug development.

The stock soared on the news, and it’s now up more than 80% year to date.

Recursion is a Utah-based biotechnology company using AI and machine learning to accelerate drug discovery and development, which represents a massive business.

At its core, Recursion is a data-driven company, as it combines high-throughput biology, automated laboratory techniques, and data-driven computational methods to generate a vast amount of biological and chemical data. The company then feeds this data into machine learning models that can identify potential drug candidates and explore their therapeutic effects across a wide range of diseases, including some cancers.

The company's platform uses human cellular models and imaging techniques to study cellular behavior and disease progression. By capturing and analyzing this comprehensive data, Recursion can uncover novel drugs and accelerate the discovery of new treatments for various diseases, including rare genetic diseases, cancer, and inflammation.

The company already works with Bayer, the University of Utah, Ohio State University, Roche, and Takeda Pharmaceuticals.

The company's ultimate goal is to transform drug discovery by combining biology, automation, and artificial intelligence to create lifesaving treatments.

Health care and AI seems like a winning combination to me.

Now let’s look at a more speculative AI company.

SoundHound AI (NASDAQ: SOUN)

SoundHound specializes in sound recognition and voice-enabled AI products.

The company has developed a range of products and services that revolve around audio and voice recognition technologies.

The company's stock has rocketed more than 100% year to date on overall optimism within the AI industry.

The company's flagship product is the SoundHound mobile app, which allows users to identify songs by simply humming, singing, or speaking a few lyrics. It uses advanced audio matching algorithms to compare the recorded sound with an extensive database of songs.

SoundHound also offers a voice-enabled AI assistant called Hound. Hound provides voice-controlled interaction and learns from your natural language. Users can ask complex and detailed questions or issue voice commands for tasks like finding information, making restaurant reservations, playing music, getting weather updates, etc.

This technology has also been utilized in other applications and services. The company has partnered with automotive manufacturers to integrate its voice recognition technology into vehicles, enabling drivers to control various functions using voice commands. Additionally, SoundHound has developed voice-enabled solutions for smart speakers, internet of things (IoT) devices, and other connected products.

SoundHound currently works with Mercedes-Benz, Qualcomm, Netflix, Pandora, Mastercard, and Square.

Is AI for Real?

All these companies sound great on paper, but time will tell whether they're profitable or not.

We've been buying AI companies hand over fist since the start of the year, though.

That's because there's a big catalyst coming up that you'll want keep an eye on…

There are rumors floating around that an AI-powered personal assistant could be on the horizon.

And the top AI companies are battling it out as we speak to gain market share.

We like one tiny AI company above the rest.

Find out why here.

Stay frosty,

Alexander Boulden
Editor, Wealth Daily

Check us out on YouTube!

After Alexander’s passion for economics and investing drew him to one of the largest financial publishers in the world, where he rubbed elbows with former Chicago Board Options Exchange floor traders, Wall Street hedge fund managers, and International Monetary Fund analysts, he decided to take up the pen and guide others through this new age of investing.

Alexander is the investment director of Insider Stakeout — a weekly investment advisory service dedicated to tracking the smartest money on the planet so that his readers can achieve life-altering, market-beating returns. He also serves at the managing editor for R.I.C.H. Report, a comprehensive service that uses the highest-quality investment research and strategies that guides its members in growing their wealth on top of preserving it.

Check out his editor’s page here.

Want to hear more from Alexander? Sign up to receive emails directly from him ranging from market commentaries to opportunities that he has his eye on.